Innovative Diagnosis and Therapeutic Modalities: Engineered Exosomes in Autoimmune Disease

References

• Hayter SM, Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev. 2012;11(10):754–765. doi:10.1016/j.autrev.2012.02.001
   PubMed Web of Science ®Google Scholar
• Abdolmaleki F, Kovanen PT, Mardani R, et al. Resolvins: emerging players in autoimmune and inflammatory diseases. Clin Rev Allergy Immunol. 2020;58(1):82–91. doi:10.1007/s12016-019-08754-9
   PubMed Web of Science ®Google Scholar
• Harding C, Heuser J, Stahl P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol. 1983;97(2):329–339. doi:10.1083/jcb.97.2.329
   PubMed Web of Science ®Google Scholar
• Song J, Kim D, Han J, et al. PBMC and exosome-derived Hotair is a critical regulator and potent marker for rheumatoid arthritis. Clin Exp Med. 2015;15(1):121–126. doi:10.1007/s10238-013-0271-4
   PubMed Web of Science ®Google Scholar
• Tian T, Cao L, He C, et al. Targeted delivery of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia. Theranostics. 2021;11(13):6507–6521. doi:10.7150/thno.56367
   PubMed Web of Science ®Google Scholar
• T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/35710644/. Accessed September 18, 2023.
   Google Scholar
• Harrell CR, Jovicic N, Djonov V, et al. Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases. Cells. 2019;8(12):1605. doi: 10.3390/cells8121605.
   PubMed Web of Science ®Google Scholar
• Zhang W, Huang Q, Xiao W, et al. Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis. Front Immunol. 2020;11:18. doi:10.3389/fimmu.2020.00018
   PubMed Web of Science ®Google Scholar
• Liang Y, Duan L, Lu J, et al. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11(7):3183–3195. doi:10.7150/thno.52570
   PubMed Web of Science ®Google Scholar
• Plant exosome-like nanovesicles: emerging therapeutics and drug delivery nanoplatforms - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/33278566/. Accessed November 27, 2022.
   Google Scholar
• Shigemoto-Kuroda T, Oh JY, Kim DK, et al. MSC-derived extracellular vesicles attenuate immune responses in two autoimmune murine models: type 1 diabetes and uveoretinitis. Stem Cell Reports. 2017;8(5):1214–1225. doi:10.1016/j.stemcr.2017.04.008
   PubMed Web of Science ®Google Scholar
• A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/33484965/. Accessed November 27, 2022.
   Google Scholar
• Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/28435469/. Accessed September 18, 2023.
   Google Scholar
• Meng X, Zheng M, Yu M, et al. Transplantation of CRISPRa system engineered IL10-overexpressing bone marrow-derived mesenchymal stem cells for the treatment of myocardial infarction in diabetic mice. J Biol Eng. 2019;13:49. doi:10.1186/s13036-019-0163-6
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Seow Y, Yin H, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341–345. doi:10.1038/nbt.1807
   PubMed Web of Science ®Google Scholar
• Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/29040874/. Accessed September 18, 2023.
   Google Scholar
• Cao Y, Wu T, Zhang K, et al. Engineered exosome-mediated near-infrared-II region V2C quantum dot delivery for nucleus-target low-temperature photothermal therapy. ACS Nano. 2019;13(2):1499–1510. doi:10.1021/acsnano.8b07224
   PubMed Web of Science ®Google Scholar
• Exosomes as drug delivery vehicles for Parkinson’s disease therapy - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/25836593/. Accessed November 27, 2022.
   Google Scholar
• Hatakeyama H, Murata M, Sato Y, et al. The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice. J Control Release. 2014;173:43–50.
   PubMed Web of Science ®Google Scholar
• Hashizume M, Hayakawa N, Mihara M. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Rheumatology. 2008;47(11):1635–1640. doi:10.1093/rheumatology/ken363
   PubMed Web of Science ®Google Scholar
• Deng C, Hu Y, Conceição M, et al. Oral delivery of layer-by-layer coated exosomes for colitis therapy. J Control Release. 2023;354:635–650. doi:10.1016/j.jconrel
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang C, Meng J, et al. A targeted exosome therapeutic confers both CfDNA scavenging and macrophage polarization for ameliorating rheumatoid arthritis. Adv Mater. 2023;35(48):e2302503. doi:10.1002/adma
   PubMed Web of Science ®Google Scholar
• Liang Y, Xu X, Li X, et al. Chondrocyte-targeted microRNA delivery by engineered exosomes toward a cell-free osteoarthritis therapy. ACS Appl Mater Interfaces. 2020;12(33):36938–36947. doi:10.1021/acsami
   PubMed Web of Science ®Google Scholar
• Li Q, Hu W, Huang Q, et al. MiR146a-loaded engineered exosomes released from silk fibroin patch promote diabetic wound healing by targeting IRAK1. Signal Transduct Target Ther. 2023;8(1):62. doi:10.1038/s41392-022-01263-w
   PubMed Web of Science ®Google Scholar
• Kanuma T, Yamamoto T, Kobiyama K, et al. CD63-mediated antigen delivery into extracellular vesicles via DNA vaccination results in robust CD8+ T cell responses. J Immunol. 2017;198(12):4707–4715. doi:10.4049/jimmunol
   PubMed Web of Science ®Google Scholar
• Jiang X, Shi L, Feng H, Zhang Y, Dong J, Shen Z. Engineered Exosomes loaded with triptolide: an innovative approach to enhance therapeutic efficacy in rheumatoid arthritis. Int Immunopharmacol. 2024;129:111677. doi:10.1016/j.intimp
   PubMed Web of Science ®Google Scholar
• Momen-Heravi F, Bala S, Bukong T, Szabo G. Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages. Nanomedicine. 2014;10(7):1517–1527. doi:10.1016/j.nano
   PubMed Web of Science ®Google Scholar
• Ge L, Wang K, Lin H, et al. Engineered exosomes derived from miR-132-overexpresssing adipose stem cells promoted diabetic wound healing and skin reconstruction. Front Bioeng Biotechnol. 2023;11:1129538. doi:10.3389/fbioe.2023.1129538
   PubMed Web of Science ®Google Scholar
• Meng HY, Chen LQ, Chen LH. The inhibition by human MSCs-derived miRNA-124a overexpression exosomes in the proliferation and migration of rheumatoid arthritis-related fibroblast-like synoviocyte cell. BMC Musculoskelet Disord. 2020;21(1):150. doi:10.1186/s12891-020-3159-y
   PubMed Web of Science ®Google Scholar
• Zhang B, Gu J, Wang Y, et al. TNF-α stimulated exosome derived from fibroblast-like synoviocytes isolated from rheumatoid arthritis patients promotes HUVEC migration, invasion and angiogenesis by targeting the miR-200a-3p/KLF6/VEGFA axis. Autoimmunity. 2023;56(1):2282939. doi:10.1080/08916934.2023.2282939
   PubMed Web of Science ®Google Scholar
• Chen X, Su C, Wei Q, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate diffuse alveolar hemorrhage associated with systemic lupus erythematosus in mice by promoting M2 macrophage polarization via the microRNA-146a-5p/NOTCH1 axis. Immunol Invest. 2022;51(7):1975–1993. doi:10.1080/08820139.2022.2090261
   PubMed Web of Science ®Google Scholar
• Mechanisms of M2 macrophage-derived exosomal long non-coding RNA PVT1 in regulating Th17 cell response in experimental autoimmune encephalomyelitisa - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/33013847/. Accessed November 27, 2022.
   Google Scholar
• You DG, Lim GT, Kwon S, et al. Metabolically engineered stem cell–derived exosomes to regulate macrophage heterogeneity in rheumatoid arthritis. Sci Adv. 2021;7(23):eabe0083. doi:10.1126/sciadv.abe0083
   PubMed Web of Science ®Google Scholar
• An injectable hydrogel scaffold with IL-1β-activated MSC-derived exosomes for the treatment of endometritis - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/36602019/. Accessed June 11, 2023.
   Google Scholar
• The role of miRNAs in immune cell development, immune cell activation, and tumor immunity: with a focus on macrophages and natural killer cells - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/31554344/. Accessed September 18, 2023.
   Google Scholar
• Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo - search results - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/?term=Interaction+between+phosphatidylserine+and+the+phosphatidylserine+receptor+inhibits+immune+responses+in+vivo&sort=date. Accessed September 18, 2023.
   Google Scholar
• Zhang L, Qin Z, Sun H, et al. Nanoenzyme engineered neutrophil-derived exosomes attenuate joint injury in advanced rheumatoid arthritis via regulating inflammatory environment. Bioact Mater. 2022;18:1–14. doi:10.1016/j.bioactmat.2022.02.017
   PubMed Web of Science ®Google Scholar
• Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/35836795/. Accessed November 27, 2022.
   Google Scholar
• Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/32111836/. Accessed November 27, 2022.
   Google Scholar
• Rodríguez-Muguruza S, Altuna-Coy A, Castro-Oreiro S, et al. A serum biomarker panel of exomiR-451a, exomiR-25-3p and soluble TWEAK for early diagnosis of rheumatoid arthritis. Front Immunol. 2021;12:790880. doi:10.3389/fimmu.2021.790880
   PubMed Web of Science ®Google Scholar
• Tzeng HT, Chyuan IT. Immunometabolism in systemic lupus erythematosus: relevant pathogenetic mechanisms and potential clinical applications. J Formos Med Assoc. 2021;120(9):1667–1675. doi:10.1016/j.jfma.2021.03.019
   PubMed Web of Science ®Google Scholar
• Xu H, Chen W, Zheng F, et al. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network in systemic lupus erythematosus. Lupus. 2020;29(4):398–406. doi:10.1177/0961203320908927
   PubMed Web of Science ®Google Scholar
• A plasmonic nanoparticle-embedded polydopamine substrate for fluorescence detection of extracellular vesicle biomarkers in serum and urine from patients with systemic lupus erythematosus - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/35649328/. Accessed September 17, 2023.
   Google Scholar
• A novel serum tsRNA for diagnosis and prediction of nephritis in SLE - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/34867955/. Accessed September 17, 2023.
   Google Scholar
• Ruiz-Irastorza G, Bertsias G. Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs. Rheumatology. 2020;59(Suppl5):v69–v81. doi:10.1093/rheumatology/keaa403
   PubMedGoogle Scholar
• T F, Az H, S S, et al. miRNA-146a improves immunomodulatory effects of MSC-derived exosomes in rheumatoid arthritis. Curr Gene Ther. 2020;20(4). doi:10.2174/1566523220666200916120708
   Web of Science ®Google Scholar
• Mesenchymal stem cell-derived exosomes suppress proliferation of T cells by inducing cell cycle arrest through p27kip1/Cdk2 signaling - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/32554049/. Accessed August 6, 2023.
   Google Scholar
• Ortega A, Martinez-Arroyo O, Forner MJ, et al. Exosomes as drug delivery systems: endogenous nanovehicles for treatment of systemic lupus erythematosus. Pharmaceutics. 2020;13(1):3. doi:10.3390/pharmaceutics13010003
   PubMed Web of Science ®Google Scholar
• Sprecher M, Maurer B, Distler O. [Primary Sjögren’s Syndrome - News on Diagnostics and Therapy]. Praxis. 2020;109(5):333–339. Swedish. doi:10.1024/1661-8157/a003442
   PubMedGoogle Scholar
• Li W, Wang H, Zhao Z, et al. Emerging nanotechnologies for liquid biopsy: the detection of circulating tumor cells and extracellular vesicles. Adv Mater. 2019;31(45):e1805344. doi:10.1002/adma.201805344
   PubMed Web of Science ®Google Scholar
• Hu L, Zhang T, Ma H, et al. Discovering the secret of diseases by incorporated tear exosomes analysis via rapid-isolation system: iTEARS. ACS Nano. 2022;16(8):11720–11732. doi:10.1021/acsnano.2c02531
   PubMed Web of Science ®Google Scholar
• Ren K. Exosomes in perspective: a potential surrogate for stem cell therapy. Odontology. 2019;107(3):271–284. doi:10.1007/s10266-018-0395-9
   PubMed Web of Science ®Google Scholar
• Rui K, Hong Y, Zhu Q, et al. Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren’s syndrome by modulating the function of myeloid-derived suppressor cells. Cell Mol Immunol. 2021;18(2):440–451. doi:10.1038/s41423-020-00587-3
   PubMed Web of Science ®Google Scholar
• Baharlooi H, Azimi M, Salehi Z, et al. Mesenchymal stem cell-derived exosomes: a promising therapeutic ace card to address autoimmune diseases. Int J Stem Cells. 2020;13(1):13–23. doi:10.15283/ijsc19108
   PubMed Web of Science ®Google Scholar
• Mesenchymal stem cells deliver exogenous microRNA-let7c via exosomes to attenuate renal fibrosis - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/27203438/. Accessed November 27, 2022.
   Google Scholar
• Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/24088962/. Accessed September 17, 2023.
   Google Scholar
• Colletti M, Galardi A, De Santis M, et al. Exosomes in systemic sclerosis: messengers between immune, vascular and fibrotic components? Int J Mol Sci. 2019;20(18):4337. doi:10.3390/ijms20184337
   PubMed Web of Science ®Google Scholar
• Microvesicle transfer of kinin B1-receptors is a novel inflammatory mechanism in vasculitis - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/27914700/. Accessed November 27, 2022.
   Google Scholar
• Proteinase 3 Is a phosphatidylserine-binding protein that affects the production and function of microvesicles - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/26961880/. Accessed November 27, 2022.
   Google Scholar
• Increased miR-142-3p expression might explain reduced regulatory T cell function in granulomatosis with polyangiitis - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/31572380/. Accessed November 27, 2022.
   Google Scholar
• Antoniades W, Grimsey N. Generating an exosome packaged p38 inhibitory peptide to block GPCR induced vascular inflammation. FASEB j. 2021;35(S1):2. doi:10.1096/fasebj.2021.35.S1.04130
   Google Scholar
• Cell membrane-formed nanovesicles for disease-targeted delivery - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/26778696/. Accessed November 27, 2022.
   Google Scholar
• Transfer of microRNA-22-3p by M2 macrophage-derived extracellular vesicles facilitates the development of ankylosing spondylitis through the PER2-mediated Wnt/β-catenin axis - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/35606376/. Accessed November 27, 2022.
   Google Scholar
• Xu X, Liang Y, Li X, et al. Exosome-mediated delivery of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration. Biomaterials. 2021;269:120539. doi:10.1016/j.biomaterials.2020.120539
   PubMed Web of Science ®Google Scholar
• Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/29445851/. Accessed November 27, 2022.
   Google Scholar
• Lv Q, Deng J, Chen Y, et al. Engineered human adipose stem-cell-derived exosomes loaded with miR-21-5p to promote diabetic cutaneous wound healing. Mol Pharm. 2020;17(5):1723–1733. doi:10.1021/acs.molpharmaceut.0c00177
   PubMed Web of Science ®Google Scholar
• Emerging roles of exosomes in T1DM - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/33324409/. Accessed November 27, 2022.
   Google Scholar
• Bone marrow-derived mesenchymal stem cells improve diabetes-induced cognitive impairment by exosome transfer into damaged neurons and astrocytes - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/27102354/. Accessed September 18, 2023.
   Google Scholar
• Doğanlar ZB, Doğanlar O, Kurtdere K, et al. Melatonin prevents blood-retinal barrier breakdown and mitochondrial dysfunction in high glucose and hypoxia-induced in vitro diabetic macular edema model. Toxicol In Vitro. 2021;75:105191. doi:10.1016/j.tiv.2021.105191
   PubMed Web of Science ®Google Scholar
• Liraglutide alleviates H2O2-induced retinal ganglion cells injury by inhibiting autophagy through mitochondrial pathways - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/28450048/. Accessed September 18, 2023.
   Google Scholar
• Mesenchymal stem cell and derived exosome as small RNA carrier and Immunomodulator to improve islet transplantation - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/27475298/. Accessed November 27, 2022.
   Google Scholar
• Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/25899407/. Accessed November 27, 2022.
   Google Scholar
• Why the need and how to approach the functional diversity of extracellular vesicles - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/29158309/. Accessed November 27, 2022.
   Google Scholar
• Engineering hybrid exosomes by membrane fusion with liposomes - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/26911358/. Accessed January 10, 2023.
   Google Scholar
• Piffoux M, Silva AKA, Wilhelm C, et al. Modification of extracellular vesicles by fusion with liposomes for the design of personalized biogenic drug delivery systems. ACS Nano. 2018;12(7):6830–6842. doi:10.1021/acsnano.8b02053
   PubMed Web of Science ®Google Scholar
• Design and application of hydrophilic bimetallic metal-organic framework magnetic nanoparticles for rapid capture of exosomes - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/34756265/. Accessed November 27, 2022.
   Google Scholar
• Zheng W, He R, Liang X, et al. Cell-specific targeting of extracellular vesicles though engineering the glycocalyx. J Extracell Ves. 2022;11(12):e12290. doi:10.1002/jev2.12290
   PubMed Web of Science ®Google Scholar
• Activating an adaptive immune response from a hydrogel scaffold imparts regenerative wound healing - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/33168979/. Accessed November 27, 2022.
   Google Scholar
• Injectable mussel-inspired highly adhesive hydrogel with exosomes for endogenous cell recruitment and cartilage defect regeneration - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/34626937/. Accessed September 18, 2023.
   Google Scholar
• Li W, Liu Y, Zhang P, et al. Tissue-engineered bone immobilized with human adipose stem cells-derived exosomes promotes bone regeneration. ACS Appl Mater Inter. 2018;10(6):5240–5254. doi:10.1021/acsami.7b17620
   PubMed Web of Science ®Google Scholar
• Meng W, He C, Hao Y, et al. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source. Drug Deliv. 2020;27(1):585–598. doi:10.1080/10717544.2020.1748758
   PubMed Web of Science ®Google Scholar
• Decellularized extracellular matrix scaffolds: recent trends and emerging strategies in tissue engineering - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/34901526/. Accessed November 27, 2022.
   Google Scholar
• Exosomes from human adipose-derived stem cells promote proliferation and migration of skin fibroblasts - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/28940813/. Accessed November 27, 2022.
   Google Scholar